vs
Side-by-side financial comparison of Chemours Co (CC) and Incyte (INCY). Click either name above to swap in a different company.
Chemours Co is the larger business by last-quarter revenue ($1.3B vs $1.3B, roughly 1.0× Incyte). Incyte runs the higher net margin — 23.8% vs -3.5%, a 27.4% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (20.9% vs -2.1%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs -1.2%).
The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
CC vs INCY — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.3B |
| Net Profit | $-47.0M | $303.3M |
| Gross Margin | 11.7% | — |
| Operating Margin | — | 23.7% |
| Net Margin | -3.5% | 23.8% |
| Revenue YoY | -2.1% | 20.9% |
| Net Profit YoY | -261.5% | 91.7% |
| EPS (diluted) | $-0.32 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | $1.5B | $1.1B | ||
| Q2 24 | $1.6B | $1.0B |
| Q1 26 | — | $303.3M | ||
| Q4 25 | $-47.0M | $299.3M | ||
| Q3 25 | $46.0M | $424.2M | ||
| Q2 25 | $-380.0M | $405.0M | ||
| Q1 25 | $-5.0M | $158.2M | ||
| Q4 24 | $-13.0M | $201.2M | ||
| Q3 24 | $-32.0M | $106.5M | ||
| Q2 24 | $60.0M | $-444.6M |
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | 92.0% | ||
| Q3 25 | 15.6% | 92.8% | ||
| Q2 25 | 17.2% | 93.5% | ||
| Q1 25 | 17.3% | 93.0% | ||
| Q4 24 | 19.4% | 92.5% | ||
| Q3 24 | 19.0% | 92.4% | ||
| Q2 24 | 19.8% | 92.7% |
| Q1 26 | — | 23.7% | ||
| Q4 25 | — | 22.3% | ||
| Q3 25 | 2.5% | 32.5% | ||
| Q2 25 | -15.4% | 43.6% | ||
| Q1 25 | — | 19.5% | ||
| Q4 24 | -0.1% | 25.6% | ||
| Q3 24 | -2.1% | 12.8% | ||
| Q2 24 | 4.4% | -45.8% |
| Q1 26 | — | 23.8% | ||
| Q4 25 | -3.5% | 19.9% | ||
| Q3 25 | 3.1% | 31.1% | ||
| Q2 25 | -23.5% | 33.3% | ||
| Q1 25 | -0.4% | 15.0% | ||
| Q4 24 | -1.0% | 17.1% | ||
| Q3 24 | -2.1% | 9.4% | ||
| Q2 24 | 3.9% | -42.6% |
| Q1 26 | — | $1.47 | ||
| Q4 25 | $-0.32 | $1.46 | ||
| Q3 25 | $0.31 | $2.11 | ||
| Q2 25 | $-2.53 | $2.04 | ||
| Q1 25 | $-0.03 | $0.80 | ||
| Q4 24 | $-0.07 | $0.90 | ||
| Q3 24 | $-0.22 | $0.54 | ||
| Q2 24 | $0.39 | $-2.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $670.0M | — |
| Total DebtLower is stronger | $4.1B | — |
| Stockholders' EquityBook value | $250.0M | $5.6B |
| Total Assets | $7.4B | $7.3B |
| Debt / EquityLower = less leverage | 16.40× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $670.0M | $3.1B | ||
| Q3 25 | $613.0M | $2.5B | ||
| Q2 25 | $502.0M | $2.0B | ||
| Q1 25 | $464.0M | $1.9B | ||
| Q4 24 | $713.0M | $1.7B | ||
| Q3 24 | $596.0M | $1.3B | ||
| Q2 24 | $604.0M | $987.3M |
| Q1 26 | — | — | ||
| Q4 25 | $4.1B | — | ||
| Q3 25 | $4.1B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.1B | — | ||
| Q4 24 | $4.1B | — | ||
| Q3 24 | $4.0B | — | ||
| Q2 24 | $4.0B | — |
| Q1 26 | — | $5.6B | ||
| Q4 25 | $250.0M | $5.2B | ||
| Q3 25 | $274.0M | $4.7B | ||
| Q2 25 | $228.0M | $4.2B | ||
| Q1 25 | $566.0M | $3.7B | ||
| Q4 24 | $571.0M | $3.4B | ||
| Q3 24 | $643.0M | $3.2B | ||
| Q2 24 | $714.0M | $3.0B |
| Q1 26 | — | $7.3B | ||
| Q4 25 | $7.4B | $7.0B | ||
| Q3 25 | $7.5B | $6.3B | ||
| Q2 25 | $7.5B | $5.8B | ||
| Q1 25 | $7.4B | $5.7B | ||
| Q4 24 | $7.5B | $5.4B | ||
| Q3 24 | $7.5B | $5.0B | ||
| Q2 24 | $7.2B | $4.7B |
| Q1 26 | — | — | ||
| Q4 25 | 16.40× | — | ||
| Q3 25 | 14.96× | — | ||
| Q2 25 | 17.99× | — | ||
| Q1 25 | 7.18× | — | ||
| Q4 24 | 7.11× | — | ||
| Q3 24 | 6.20× | — | ||
| Q2 24 | 5.53× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $137.0M | — |
| Free Cash FlowOCF − Capex | $92.0M | — |
| FCF MarginFCF / Revenue | 6.9% | — |
| Capex IntensityCapex / Revenue | 3.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $51.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $137.0M | $543.3M | ||
| Q3 25 | $146.0M | $559.4M | ||
| Q2 25 | $93.0M | $44.7M | ||
| Q1 25 | $-112.0M | $266.1M | ||
| Q4 24 | $138.0M | $381.2M | ||
| Q3 24 | $139.0M | $310.9M | ||
| Q2 24 | $-620.0M | $-575.6M |
| Q1 26 | — | — | ||
| Q4 25 | $92.0M | — | ||
| Q3 25 | $105.0M | — | ||
| Q2 25 | $50.0M | — | ||
| Q1 25 | $-196.0M | — | ||
| Q4 24 | $29.0M | — | ||
| Q3 24 | $63.0M | — | ||
| Q2 24 | $-693.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.9% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | -14.3% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 4.2% | — | ||
| Q2 24 | -44.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | — | ||
| Q3 25 | 2.7% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 5.0% | — | ||
| Q2 24 | 4.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.82× | ||
| Q3 25 | 3.17× | 1.32× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 1.68× | ||
| Q4 24 | — | 1.89× | ||
| Q3 24 | — | 2.92× | ||
| Q2 24 | -10.33× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CC
| Titanium Technologies | $563.0M | 42% |
| Thermal And Specialized Solutions | $443.0M | 33% |
| Advanced Performance Materials | $312.0M | 23% |
| Other Non-Reportable Segment | $12.0M | 1% |
INCY
Segment breakdown not available.
